{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-108626","form_type":"8-K","ticker":null,"cik":"0001971543","company_name":"Mural Oncology plc","filed_at":"2024-09-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.300958+00:00","generated_at":"2026-05-31T02:34:21.236979+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Mural Oncology appoints Sachiyo Minegishi as independent director and Audit Committee chair","bullets":["Appointed as director effective Sept 20, 2024; initial term through 2025 AGM.","Also named Chair of Audit Committee and member of Nominating & Corporate Governance Committee.","Received option for 15,335 ordinary shares at $3.38 (closing price), vesting quarterly over 3 years.","Annual cash compensation of $40,000 plus additional committee fees and equity grants.","Determined independent under Nasdaq rules; no family relationships or transactions with company."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-108626","json":"https://secwatch.observer/filing/0000950170-24-108626.json","markdown":"https://secwatch.observer/filing/0000950170-24-108626.md","text":"https://secwatch.observer/filing/0000950170-24-108626.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024108626/0000950170-24-108626-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024108626/mura-20240920.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:34:21.236979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70578834d0","claim":"Sachiyo Minegishi was appointed as Director and Chair of the Audit Committee at Mural Oncology plc.","evidence_excerpt":"On September 20, 2024, the Board of Directors (the “Board”) of Mural Oncology plc (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Sachiyo Minegishi as a director in accordance with the Company’s articles of association to serve on the Board with an initial term expiring at the Company’s 2025 annual general meeting.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971543/000095017024108626/0000950170-24-108626-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Chair of the Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}